Choose your screen resolution: Auto adjust 800x600 1024x768

Information

Login

Lost Password?
No account yet? Register

Please Visit

Advertisement

In the News

Filter     Order     Display # 
Item Title Hits
MMSupport.net unveils “Ask the Expert”, featuring Dr. James R. Berenson 980
Stem cells make bone marrow cancer resistant to treatment 871
Norepinephrine could hasten the progression of certain blood cancers 1057
Researchers to Investigate Ways to Better Diagnose Autoimmune Disorders 905
Velcade Before and After SCT for Newly Diagnosed 1591
Research From Cleveland Clinic Provides New Insights Into Relapsed Or Refractory Multiple Myeloma 1658
Mayo Clinic Cancer Center Researchers Find That a Byproduct of Mold Kills Multiple Myeloma 1974
Mayo Clinic Cancer Center -- Investigating the Measles Virus as a Tool to Kill Multiple Myeloma 1644
A chemotherapy drug packs a one-two punch 1762
New Findings from the Mayo Clinic 2150
Circulating Cancer Cells Indicate Worse Outcomes Following Autologous Stem Cell Transplant 2263
An advanced genetic diagnostic method for multiple myeloma 682
Drug Fights Multiple Myeloma by Putting "Brakes" on Cell Proliferation, Weill Cornell Team Reports 854
Gene Called Link Between Life Span and Cancers 556
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of MM 832
REVLIMID (R) (Lenalidomide) Survival Data Evaluated in Previously Treated Multiple Myeloma 744
Revlimid boosts survival in multiple myeloma-study 742
New Drugs for Cancer Could Soon Flood Market 759
Thalidomide approved for cancer treatment 672
FDA approves Merck's shingles vaccine 591
A Strain of Mice Appears Able to Resist Cancer Cells 766
Mini Allogeneic Transplant Not Superior to Subsequent Autologous Stem Cell Transplant in High-Risk M 609
UAMS Myeloma Researchers on Team Analyzing Disease's Genetic Fingerprints -- Cancer Cell Publishes W 687
Scientists discover new genetic sub-types of blood cancer 772
Study shows rituximab effective in treating chronic graft-versus-host disease 568
Study Describes Osteonecrosis of the Jaw in Patients with Multiple Myeloma 717
Velcade® plus Melphalan Shows Encouraging Activity in Multiple Myeloma 685
Treanda™/Prednisone Superior to Melphalan/Prednisone for Multiple Myeloma 1093
Low Dose of Thalidomid® as Effective as Higher Dose in Relapsed Myeloma 744
Osteonecrosis of the jaw associated with pamidronate therapy 1137
Weill Cornell Team Identifies Mechanism Triggering Multiple Myeloma Relapse 1242
Revolutionary Approach to Cancer Therapy Should Increase Efficacy 963
Compound from marine bacteria shows potential as multiple myeloma therapy 969
Resveratrol Combats Bone Marrow Cancer 870
Human myeloma cell line suitable for the generation of stable human monoclonal antibodies 1134
Combination of Drugs Shows Promise for Treatment of Multiple Myeloma 736
A PHASE 1 STUDY OF BORTEZOMIB (VELCADE) IN COMBINATION WITH LENALIDOMIDE (REVLIMID) IN RELAPSED AN 706
FDA extends review date for Celgene cancer drug 723
FDA panel backs Celgene's Revlimid 731
MRI of Bone Marrow Predicts Outcomes of Multiple Myeloma 3633
Scientists say drug is good cancer fighter 1292
Velcade® Overcomes Poor Prognosis of Genetic Mutation in Multiple Myeloma 1033
Revlimid® Delays Time to Cancer Progression in Relapsed Multiple Myeloma 3209
'Smart' Immune Cells Kill More Cancer 1856
Mayo Clinic researchers create 'obedient virus'; First step to use measles virus against cancer 1905
Seattle Genetics Receives Key U.S. Patents for SGN-40 Program 1559
US FDA approves Kepivance for oral mucositis in cancer patients 1853
By impounding iron, FHC foils cell suicide, fuels inflammation 1078
Antisense Drug Targeting STAT-3 Demonstrates Significant Anti-Tumor Activity 1024
Multiple Myeloma Research Consortium launched 1677
 
<< Start < Prev 1 2 Next > End >>
Results 1 - 50 of 88

Search This Site

Tax Deductible Donation

Please support this site and online support for health challenges of all kinds, which are provided by the Online Patient Empowerment Project, a 501(c)(3) Corporation.

Search the Web

Google

Mailing Lists

Have you subscribed to the MMA interactive mailing list?  Please click HERE to subscribe. Once subscribed, you can choose a daily digest version, real time delivery and you'll have access to the list archives. To join the ACOR list, please click HERE.

Syndicate

Statistics

Visitors: 637267

Who's Online